Although neurocognitive dysfunction has been observed after infection by SARS-CoV-2, few studies have detailed these alterations or demonstrated their impact on daily life activities and work. Here, I describe the sequence of events following a mild COVID-19 infection in August 2020 (which now is described as "post-COVID syndrome") and comment on my ensuing limitations associated with cognitive difficulties, headache, fatigue and sleepiness. Furthermore, I discuss the efforts that I have made to recover from my infection since its beginning and the strategies adopted for living with persistent restrictions in terms of cognitive performance.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9387179 | PMC |
| http://dx.doi.org/10.1590/0004-282X-ANP-2022-0062 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Exploring the relationship between trauma, mental health, and occupational performance in health science center students.
Front Public Health
January 2025
Occupational Therapy Department, College of Allied Health Sciences, Kuwait University, Kuwait City, Kuwait.
Introduction: Attending university marks a pivotal yet stressful phase in students' lives, characterized by significant adjustments to a new environment that can impact mental, emotional, and physical well-being. The journey through the acceptance and admissions process into university introduces substantial challenges, academic performance and changes to daily life. Such challenges and corresponding conditions can be intensified for students entering university with prior traumatic experiences.
View Article and Find Full Text PDFUnveiling the influences of prenatal and maternal factors on the journey of an autistic child.
Front Psychiatry
December 2024
Department of Public Health and Community Medicine, Faculty of Medicine, Zagazig University, Zagazig, Egypt.
Background: Autism Spectrum Disorder (ASD) is a complex lifelong neurodevelopmental disorder with a high and increasing global prevalence. Although the precise causes are unknown, both genetic and environmental factors, including maternal ones during pregnancy, significantly influence its development. Therefore, this study endeavors to explore the potential causes of autism, including maternal and paternal prenatal risk factors, as well as antenatal and natal maternal risk factors, and their associations with the severity of ASD in mothers of children with ASD, from February to May 2024.
View Article and Find Full Text PDFReframing the Narrative: An Exploratory Study of the Concerns, Expectations and Experiences of Parents Who Bring Their Child to an Emergency Department with Non-Urgent Illness.
Compr Child Adolesc Nurs
January 2025
Child & Family Health, University of Salford, Salford, UK.
Parenthood inevitably includes caring for a child suffering from mild-moderate illness requiring access to health care. Most childhood illnesses can be managed in the community, and parents are encouraged to attend the most suitable primary care service for their needs. Yet the number of children visiting emergency departments with non-urgent illness continues to rise annually, with child attendance representing over 25% of the total workload.
View Article and Find Full Text PDFAnemia in Myelofibrosis: A Focus on Proactive Management and the Role of Momelotinib.
Cancers (Basel)
December 2024
Atrium Health Wake Forest Baptist Comprehensive Cancer Center, Wake Forest University School of Medicine, Winston-Salem, NC 27157, USA.
Anemia is a common and progressive clinical manifestation of myelofibrosis that may occur as part of the disease pathogenesis as well as due to the myelosuppressive effects of some treatments, with a substantial impact on quality of life, prognosis, and healthcare resource utilization. Despite these burdens, anemia management has traditionally been a secondary priority to spleen and symptom control, due in part to the limitations of available therapeutic approaches. With the initial regulatory approvals of momelotinib, a Janus kinase 1 (JAK1), JAK2, and activin A receptor type 1 inhibitor that provides anemia-related benefits in addition to addressing splenomegaly and symptoms, re-evaluation of anemia as an early and prominent treatment consideration is warranted.
View Article and Find Full Text PDFSickle cell disease in India: the journey and hope for the future.
Hematology Am Soc Hematol Educ Program
December 2024
Department of Paediatrics, Government Medical College, Nagpur, Maharashtra, India.
Article Synopsis
- India has a high frequency of the sickle hemoglobin (HbS) allele, and though sickle cell disease (SCD) was once considered mild in the country, recent advancements indicate its severity is on par with global standards.
- Clinical manifestations of SCD in India include vaso-occlusive crises and strokes, with affected individuals experiencing complications at a younger age, but improvements in care have led to increased survival into adulthood.
- The Government of India has initiated the National Sickle Cell Anaemia Elimination Mission to enhance screening, treatment, and education efforts, with funding aimed at developing new therapies and technologies to manage SCD.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!